Status:

SUSPENDED

Mindfulness Intervention for Caregivers of Autism in Rural Environments

Lead Sponsor:

MaineHealth

Conditions:

Stress

Anxiety

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this clinical trial is to investigate the effectiveness of a mobile app-based mindfulness program in improving the mental well-being of caregivers with a child diagnosed with autism spe...

Detailed Description

Caregivers of children with autism spectrum disorder (ASD) often experience heightened stress, anxiety, and social isolation, leading to a reduced quality of life when compared to the general populati...

Eligibility Criteria

Inclusion

  • The caregiver must be 18 years of age or older.
  • The caregiver must have a zip code classified as rural according to the Rural-Urban Commuting Area codes (RUCA) in the state of Maine.
  • The caregiver is currently living with a romantic partner (caregiver 2) who is also willing to participate in the study.
  • The caregiver's romantic partner (caregiver 2) must be 18 years of age or older.
  • The caregiver is defined as an adult, whether biological or non-biological parent/guardian, who currently resides with and provides care for a child with Autism Spectrum Disorder (ASD).
  • The caregiver must be able to speak and read English, regardless of whether English is their first language.
  • The caregiver must have the capacity to comprehend and sign an informed consent form.
  • The caregiver must be a legally authorized representative and cannot be a guardian or foster parent under the Department of Health and Human Services (DHHS).
  • The caregiver must affirm that their child has received a clinical diagnosis of ASD.
  • Both the caregiver and the child must reside at an address classified as rural according to the Rural-Urban Commuting Area codes (RUCA) in the state of Maine (identified by zip code).
  • The caregiver must possess a smartphone and have access to the internet.
  • The caregiver must agree to participate in online assessments, as well as the 30-day mindfulness intervention using the Unwinding Anxiety (UA) mobile app.

Exclusion

  • 1\. Any medical condition or impairment that would hinder the participant's ability to engage in a study that involves daily visual and auditory tasks, as well as comprehension and adherence to the study protocol. Examples of such impairments include deafness, blindness, impaired decision making capacity and impaired intellectual functioning.

Key Trial Info

Start Date :

June 15 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2025

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT06169501

Start Date

June 15 2024

End Date

June 30 2025

Last Update

May 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Glickman Lauder Center of Excellence

Portland, Maine, United States, 04102